Recombinant Human Thrombopoietin Treatment Promotes Hematopoiesis Recovery in Patients with Severe Aplastic Anemia Receiving Immunosuppressive Therapy

Table 4

Circulating reticulocyte recovery in patients treated with and without rhTPO.

Time	Reticulocyte counts (×10^9/L)		value	Reticulocyte percentage (%)		value
	With rhTPO	Without rhTPO		With rhTPO	Without rhTPO
At 3 months	57 (21–98)	42 (13–76)	0.0662	1.5 (0.2–2.9)	0.9 (0.3–1.4)	0.025^*
At 6 months	65 (28–106)	61 (22–116)	0.7022	2.2 (0.2–3.8)	1.9 (0.3–3.5)	0.486
At 9 months	82 (25–149)	79 (35–127)	0.8467	1.9 (0.2–3.6)	1.7 (0.2–3.5)	0.643

.